Evidence-informed recommendations to reduce dissemination bias in clinical research: Conclusions from the OPEN (Overcome failure to Publish nEgative fiNdings) project based on an international consensus meeting

BMJ Open

Volumn 5, Issue 5, 2015, Pages

  Meerpohl, Joerg J ^a   Schell, Lisa K ^a   Bassler, Dirk ^b,c   Gallus, Silvano ^d   Kleijnen, Jos ^e,f   Kulig, Michael ^g   Vecchia, Carlo La ^h   Marušić, Ana ⁱ   Ravaud, Philippe ^j   Reis, Andreas ^k   Schmucker, Christine ^a   Strech, Daniel ^l   Urrútia, Gerard ^m   Wager, Elizabeth ⁿ   Antes, Gerd ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^d MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^e KLEIJNEN SYSTEMATIC REVIEWS LTD   (United Kingdom)

^f MAASTRICHT UNIVERSITY   (Netherlands)

^g Medical Department   (Germany)

^h UNIVERSITY OF MILAN   (Italy)

ⁱ UNIVERSITY OF SPLIT   (Croatia)

^j INSERM   (France)

^k WORLD HEALTH ORGANIZATION   (Switzerland)

^l HANNOVER MEDICAL SCHOOL   (Germany)

^m BIOMEDICAL RESEARCH INSTITUTE SANT PAU IIB SANT PAU   (Spain)

ⁿ Sideview   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL RESEARCH; CONSENSUS; EVIDENCE BASED PRACTICE; INFORMATION DISSEMINATION; INFORMATION PROCESSING BIAS; PUBLICATION; BIOMEDICAL TECHNOLOGY ASSESSMENT; DECISION MAKING; EVIDENCE BASED MEDICINE; HUMAN; MEDICAL RESEARCH; ORGANIZATION AND MANAGEMENT; PUBLISHING; STATISTICAL BIAS;

BIAS (EPIDEMIOLOGY); BIOMEDICAL RESEARCH; CONSENSUS; DECISION MAKING; EVIDENCE-BASED MEDICINE; HUMANS; PUBLISHING; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 84930204766     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2014-006666     Document Type: Article

References (39)

1. Strech D. Normative arguments and new solutions for the unbiased registration and publication of clinical trials. J Clin Epidemiol 2012;65:276-81.
2. Dwan K, Gamble C, Williamson PR, et al. Systematic review of the empirical evidence of study publication bias and outcome reporting bias - an updated review. PLoS ONE 2013;8:e66844.
3. Antes G, Chalmers I. Under-reporting of clinical trials is unethical. Lancet 2003;361:978-9.
4. Dickersin K. The existence of publication bias and risk factors for its occurrence. JAMA 1990;263:1385-9.
5. Muller KF, Briel M, D'Amario A, et al. Defining publication bias: protocol for a systematic review of highly cited articles and proposal for a new framework. Syst Rev 2013;2:34.
6. Song F, Parekh S, Hooper L, et al. Dissemination and publication of research findings: an updated review of related biases. Health Technol Assess 2010;14:iii, ix-xi, 1-193.
7. Brown T. It's time for all trials registered and reported. Cochrane Database Syst Rev 2013;4:ED000057.
8. Doshi P, Dickersin K, Healy D, et al. Restoring invisible and abandoned trials: a call for people to publish the findings. BMJ 2013;346:f2865.
9. Groves T. What does oseltamivir do, and how will we know? BMJ 2013;347:f4687.
10. Nisen P, Rockhold F. Access to patient-level data from GlaxoSmithKline clinical trials. N Engl J Med 2013;369:475-8.
11. Littmann J, Antes G, Strech D, et al. To overcome failure to publish negative findings: The OPEN project. Maturitas 2013;76:111-12.
12. Mueller KF, Meerpohl JJ, Briel M, et al. Detecting, quantifying and adjusting for publication bias in meta-analyses: protocol of a systematic review on methods. Syst Rev 2013;2:60.
13. Schmucker C, Bluemle A, Briel M, et al. A protocol for a systematic review on the impact of unpublished studies and studies published in the gray literature in meta-analyses. Syst Rev 2013;2:24.
14. Portalupi S, von Elm E, Schmucker C, et al. Protocol for a systematic review on the extent of non-publication of research studies and associated study characteristics. Syst Rev 2013;2:2.
15. Malički M, Marušić A. Is there a solution to publication bias? Researchers call for changes in dissemination of clinical research results. J Clin Epidemiol 2014;67:1103-10.
16. Viergever RF, Karam G, Reis A, et al. The quality of registration of clinical trials: still a problem. PLoS ONE 2014;9:e84727.
17. Wager E, Williams P; Project Overcome failure to Publish nEgative fiNdings C. "Hardly worth the effort"? Medical journals' policies and their editors' and publishers' views on trial registration and publication bias: quantitative and qualitative study. BMJ 2013;347:f5248.
18. Dwan K, Altman DG, Clarke M, et al. Evidence for the selective reporting of analyses and discrepancies in clinical trials: a systematic review of cohort studies of clinical trials. PLoS Med 2014;11:e1001666.
19. Andrews J, Guyatt G, Oxman AD, et al. GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol 2013;66:719-25.
20. Andrews JC, Schunemann HJ, Oxman AD, et al. GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength. J Clin Epidemiol 2013;66:726-35.
21. Zarin DA, Tse T, Williams RJ, et al. The ClinicalTrials.gov results database - update and key issues. N Engl J Med 2011;364:852-60.
22. Hirsch L. Trial registration and results disclosure: impact of US legislation on sponsors, investigators, and medical journal editors. Curr Med Res Opin 2008;24:1683-9.
23. Jones C, Keil L, Weaver M, et al. Clinical trials registries are under-utilized in the conduct of systematic reviews: a cross-sectional analysis. Syst Rev 2014;3:126.
24. Higgins JPT, Altman DG, Sterne JAC. Chapter 8: assessing risk of bias in included studies. In: Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions version 510. (updated March 2011), Wiley-Blackwell, 2011:187-241.
25. Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions; version 5.1.0. Chichester, UK: John Wiley & Sons, Ltd, 2011. http://www.cochrane-handbook.org
26. Sterne JA, Sutton AJ, Ioannidis JP, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 2011;343:d4002.
27. Ofori-Adjei D, Antes G, Tharyan P, et al. Have online international medical journals made local journals obsolete? PLoS Med 2006;3:e359-0.
28. Gotzsche PC. Why we need easy access to all data from all clinical trials and how to accomplish it. Trials 2011;12:249.
29. Strech D, Littmann J. Lack of proportionality. Seven specifications of public interest that override post-approval commercial interests on limited access to clinical data. Trials 2012;13:100.
30. Gotzsche PC, Jorgensen AW. Opening up data at the European Medicines Agency. BMJ 2011;342:d2686.
31. Chalmers I, Glasziou P. Avoidable waste in the production and reporting of research evidence. Lancet 2009;374:86-9.
32. Chan AW, Song F, Vickers A, et al. Increasing value and reducing waste: addressing inaccessible research. Lancet 2014;383:257-66.
33. Glasziou P, Altman DG, Bossuyt P, et al. Reducing waste from incomplete or unusable reports of biomedical research. Lancet 2014;383:267-76.
34. Regulation of the European Parliament and of the Council on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC. 2014. http://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32014R0536&from=EN (accessed 5 Jun 2014).
35. Torjesen I. European drug agency backtracks on plan to give researchers access to clinical trial reports. BMJ 2014;348:g3432.
36. Goldacre B, Godlee F, Heneghan C, et al. Open letter: European Medicines Agency should remove barriers to access clinical trial data. BMJ 2014;348:g3768.
37. EMA. European Medicines Agency agrees policy on publication of clinical trial data with more user-friendly amendments. 2014. http://www.ema.europa.eu/docs/en-GB/document-library/Press-release/2014/06/WC500168342.pdf (accessed 4 Aug 2014).
38. Eden J, Levit L, Berg AO, et al. Finding what works in health care: standards for systematic reviews. National Academies Press, 2011.
39. World Health Organization. International Clinical Trials Registry Platform (ICTRP). Secondary International Clinical Trials Registry Platform (ICTRP). http://www.who.int/ictrp/en/